XML 97 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Beginning balance $ (50,306) $ (53,501) $ (53,986)
Realized and unrealized gains (losses):      
Included in regulatory liabilities 8,281 3,195 484
Included in other comprehensive income 0 0 0
Included in earnings [1] (3,718) (5,347) (6,635)
Included in current assets (9) (142) 0
Purchases 24,181 23,346 23,052
Sales 0 0 0
Issuances 0 0 0
Settlements (20,455) (17,857) (16,416)
Transfers in and/or out of Level 3 0 0 0
Ending balance (42,026) (50,306) (53,501)
Total gains (losses) included in earnings attributed to the change in unrealized gains (losses) related to assets and liabilities [1] 0 0 0
Purchased Power Expense [Member]      
Realized and unrealized gains (losses):      
Included in earnings [1] (3,314) (5,262) (6,663)
Cost Of Gas Sold Expense [Member]      
Realized and unrealized gains (losses):      
Included in earnings [1] $ (404) $ (85) $ 28
[1]

MGE's exchange-traded derivative contracts, over-the-count er party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.